ChinaBio Partnering Forum ChinaBio LLC EBD Group ChinaBio Partnering Forum Image Map
Email this page Share this on LinkedIn Share this on Twitter

ChinaBio® Partnering Forum 2015 Press Releases

October 27, 2014ChinaBio® Partnering Forum 2015 to be held in Shanghai, China April 22–23, 2015International pharma and biotech dealmakers consider event critical for cross-border BD
The 2015 edition of ChinaBio® Partnering Forum, China's premier life science partnering event, will be held April 22–23 in Shanghai. Shanghai is the largest city proper in the world and home to over 1,000 life science companies. In 2014, the Forum was attended by 848 delegates from 425 companies and 25 countries, making it the largest partnering conference in China. Phar...  more ►

partnering360:Insight Latest headlines from partnering360:Insight

January 22, 2015 Life sciences democratize research and investing Non-accredited investors are beginning to have the opportunity to invest in biotech, thanks to some innovative new financing mechanisms and the growing democratization of healthcare, according to panelists at the Biotech Showcase™ 2015 financing session. more ►

January 16, 2015 Are old financing models enough? Last year saw more than USD 400 billion returned to investors through IPO exits and a bevy of new venture funds created, but this doesn’t signal a return to business as usual. Instead biotech financing in the future must continue to look to innovative strategies and must address reimbursement questions ever earlier in the race to attract funds, according to panelists at a Biotech Showcase™ 2015 lunch plenary. more ►

January 16, 2015 Regenerative medicine creating tangible value Regenerative medicine is beginning to add real value to healthcare not just by treating disease, but by curing disease. Most people—even those in the industry—don’t realize that more than 60 regenerative products have been approved, said Edward Lanphier. Some 500 companies are operating in this space globally, with 375 ongoing clinical trials. Of those, 340 are in Phase I or Phase II. Therefore, a great many products can be expected to be commercialized in the next few years. more ►

January 16, 2015 Perceptions of value and success There’s no single definition of value in the life sciences. Big pharma, investment bankers and venture capitalists each have different goals that affect their perception of value and guide their investment decisions. Panelists at a luncheon plenary session at Biotech Showcase™ 2015 made that point patently evident. more ►

January 16, 2015 The new immuno-oncology revolution Immuno-oncology is new again, fueled by research that has many scientists thinking a cure for cancer may be possible within their lifetimes. After the cancer vaccine misses of seven years ago, investors’ interests are once again piqued. The challenge is identifying exactly where in this fast-moving, complicated space to invest, according to Stephen Dunn, President and Senior Managing Partner, LifeTech Capital, speaking at Biotech Showcase™ 2015. more ►

Arrow Up

See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2015 EBD Group, Inc.
Privacy Policy
Terms of Use
ChinaBio Partnering Forum ChinaBio LLC EBD Group ChinaBio Partnering Forum Image Map